| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 19 Dec 24 | APLT Applied Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 500,000 | 0.00 | 500,000 |
| 19 Dec 24 | APLT Applied Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.02 | 1,000,000 | 1.02 mm | 1,000,000 |
| 1 Sep 24 | AXGN AxoGen | Common Stock | Option exercise | Acquire M | No | No | 0 | 11,904 | 0.00 | 29,016 |
| 1 Sep 24 | AXGN AxoGen | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 11,904 | 0.00 | 0 |
| 18 Jun 24 | VSTM Verastem | Common Stock | Grant | Acquire A | No | No | 0 | 8,333 | 0.00 | 8,333 |
| 18 Jun 24 | VSTM Verastem | Stock Option Common Stock | Grant | Acquire A | No | No | 3.27 | 12,500 | 40.88 k | 12,500 |
| 6 Jun 24 | AXGN AxoGen | Common Stock | Grant | Acquire A | No | No | 0 | 10,653 | 0.00 | 17,112 |
| 6 Jun 24 | AXGN AxoGen | Employee Stock Option (right to purchase) Common Stock | Grant | Acquire A | No | No | 7.04 | 18,248 | 128.47 k | 18,248 |
